Serhat Gumrukcu insider trades: Enochian Biosciences (ENOB) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Serhat reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 18, 2022 | ENOB | ↓ Sell | 253,493 | $8.00 | $2.0M | Direct | May 20, 2022 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Serhat Gumrukcu's insider trades
Serhat Gumrukcu is a 10% owner of Enochian Biosciences (ENOB). Since May 18, 2022, Serhat has reported no open-market purchases and 1 sale worth $2.0M on SEC Form 4. There have been no open-market trades in the last 12 months.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ENOB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.